Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
regkirona
celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - Ónæmiskerfið sera og mótefni, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
trepulmix
scipharm sàrl - treprostinil járn - háþrýstingur, lungnabólga - blóðþurrðandi lyf - treatment of adult patients with who functional class (fc) iii or iv and:inoperable chronic thromboembolic pulmonary hypertension (cteph), orpersistent or recurrent cteph after surgical treatmentto improve exercise capacity.
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - taugakerfi - Öll önnur lækningavörur - afturköllun taugavöðvablokkunar sem valdið er af rócuronium eða vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.